IPP Bureau
Briefs: Family Care Hospitals, Laurus Labs and Bafna Pharmaceuticals
By IPP Bureau - June 30, 2024
Laurus Labs receives EIR from USFDA for API facilities
ONGC to enhance healthcare facilities at Baltal and Chandanwari in J&K
By IPP Bureau - June 30, 2024
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Orchid Pharma and Cipla collaborate to launch antibiotic Cefepime-Enmetazobactam in India
By IPP Bureau - June 29, 2024
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Alembic Pharmaceuticals announces USFDA final approval for Doxycycline Capsules, 40 mg
By IPP Bureau - June 29, 2024
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
HCG acquires 51% stake in Mahatma Gandhi Cancer Hospital and Research Institute, Vizag
By IPP Bureau - June 29, 2024
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Aurobindo Pharma’s subsidiary acquires Ace Laboratories, UK
By IPP Bureau - June 29, 2024
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Jubilant Ingrevia receives EIR from USFDA for Unit-1 at Bharuch
By IPP Bureau - June 28, 2024
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Eugia SEZ’s injectable facility gets EIR from USFDA
By IPP Bureau - June 28, 2024
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
ANG Lifesciences India updates on acquisition of unit from Ind-Swift
By IPP Bureau - June 28, 2024
This plant is located at Baddi, Himachal Pradesh spread over an area of 2.85 acres
Pfizer and BioNTech receive Positive CHMP opinion for Omicron JN.1-adapted COVID-19 vaccine in EU
By IPP Bureau - June 28, 2024
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Sanofi Consumer Healthcare India appoints Himanshu Bakshi as MD
By IPP Bureau - June 27, 2024
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
.jpg "Glenmark and IADVL undertake awareness campaign supporting vitiligo patients in India")
Glenmark and IADVL undertake awareness campaign supporting vitiligo patients in India
By IPP Bureau - June 27, 2024
Glenmark released Picture Post Cards on World Vitiligo Day
Aster DM Healthcare achieves NABH Digital Standards' Platinum Certification for Aster CMI Hospital
By IPP Bureau - June 27, 2024
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
Shilpa Medicare Bio Analytical unit gets "No Action Indicated" classification from USFDA
By IPP Bureau - June 27, 2024
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
